Drug delivery systems are developed to reduce off-target side effects, protect drugs from degradation and control release of the therapeutic agents at the desired sites.The pharmacological intervention of osteoporosis has substantially progressed for decades. However, the existing therapies have certain limitations including efficacy and long-term safety issues,to solve these problems, it is highly desirable to develop drug delivery systems, which might protect the incorporated drug from degradation, provide a controlled release, or
effectively enhance the concentration of therapeutic agents at the disease site and therefore decrease the off-target toxicity. Hence, Drug delivery systems are developed to overcome these limitations. Drug delivery systems based on these targeting moieties have been developed to obtain osteotropicity.drug delivery modalities aim to reduce off-target side effects, protects drugs from degradation and controlled release of the therapeutic agents at the desired sites. (Yijia Zhang, AnandDusad and KeRen, Drug Delivery Strategies for Treating Osteoporosis)
A collaboration set up recently with 100 international societies would provide a window to wider knowledge-base of worldwide open access health-related information. As part of its drive to boost knowledge-sharing through real-time interaction, this open access group has been organizing over 100 world-class scientific conferences at global venues through the calendar year. Abstracts presented at the meets are invited from scholars with a track record of effective research papers that are also published as special journal issue for each of the conference.About 700+ peer-reviewed journals are handled by more than 25000 editorial board members who belong to both academic and industrial circles in all aspects of Science, Engineering, Management and Technology journals.
Last date updated on July, 2014